Structure

InChI Key OLVCFLKTBJRLHI-AXAPSJFSSA-N
Smiles Cn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](O)c3ccccc3)[C@H]2SC1
InChI
InChI=1S/C18H18N6O5S2/c1-23-18(20-21-22-23)31-8-10-7-30-16-11(15(27)24(16)12(10)17(28)29)19-14(26)13(25)9-5-3-2-4-6-9/h2-6,11,13,16,25H,7-8H2,1H3,(H,19,26)(H,28,29)/t11-,13-,16-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C18H18N6O5S2
Molecular Weight 462.51
AlogP -0.23
Hydrogen Bond Acceptor 10.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 7.0
Polar Surface Area 150.54
Molecular species ACID
Aromatic Rings 2.0
Heavy Atoms 31.0

Bioactivity

Mechanism of Action Action Reference
Bacterial penicillin-binding protein inhibitor INHIBITOR PubMed PubMed PubMed PubMed
Assay Description Organism Bioactivity Reference
TP_TRANSPORTER: inhibition of Estrone sulfate uptake in OAT3-expressing S2 cells None 46.0 nM
TP_TRANSPORTER: inhibition of PAH uptake in OAT1-expressing S2 cells None 30.0 nM
Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake at 20 uM by scintillation counting Homo sapiens 30.2 %
Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake at 20 uM incubated for 5 mins by scintillation counting Homo sapiens 16.5 %
Inhibition of human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E3S uptake at 20 uM incubated for 5 mins by scintillation counting Homo sapiens 2.7 %

Related Entries

Cross References

Resources Reference
ChEBI 3480
ChEMBL CHEMBL1146
DrugBank DB01326
DrugCentral 527
FDA SRS 5CKP8C2LLI
Human Metabolome Database HMDB0015421
KEGG C06879
PDB SMX
PharmGKB PA448837
PubChem 456255
SureChEMBL SCHEMBL37287
ZINC ZINC000003830394